Special 301 report retained India on its Priority Watch List.
India is a signatory to Berne Convention, which governs copyright.
India doesn’t have patent protection of pharmaceutical products.
Which of the statements given above is/are correct? Answer:
Only 1 & 2
Notes:
The U.S. Trade Representative in its annual Special 301 report decided to retain India on its Priority Watch List along with six other countries- Argentina, Chile, China, Indonesia, Russia and Venezuela.
Under the Indian Patent Act of 1970, patents are granted if the invention fulfils the following criteria: It should be novel; It should have inventive step/s or it must be non-obvious; It should be capable of Industrial application; It should not attract the provisions of sections 3 and 4 of the Patents Act 1970.
India is a party to the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement
India is also a signatory to Berne Convention, which governs copyright, the Budapest Treaty, the Paris Convention for the Protection of Industrial Property, and the Patent Cooperation Treaty (PCT), all of which govern various patent-related matters.
Based on the recommendation of Rajagopala Ayyangar commission (1959), the original Indian Patents Act did not grant patent protection to pharmaceutical products to ensure that medicines were available to the masses at a low price.
Patent protection of pharmaceuticals was re-introduced after the 2005 amendment to comply with TRIPS.